Top compounds associated with response to CC2D2B


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.6
mRNA pitstop2 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.6
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA JW-74 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.034 0.6
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.026 0.6
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.021 0.6
mRNA thalidomide CTRPv2 pan-cancer AAC -0.025 0.6
mRNA semagacestat CTRPv2 pan-cancer AAC 0.017 0.6
Download CSV